CNBC February 26, 2025
Annika Kim Constantino

Key Points

– Eli Lilly said it will invest at least $27 billion to build four new manufacturing sites in the U.S. as demand for its weight loss and diabetes injections soars and the company develops new drugs.

– The move comes as companies work to build goodwill with President Donald Trump, who has emphasized reshoring manufacturing to the U.S. and reducing reliance on foreign supply chains.

– The announcement brings Eli Lilly’s total U.S. manufacturing investments to more than $50 billion in recent years.

Eli Lilly on Wednesday said it will invest at least $27 billion to build four new manufacturing sites in the U.S., as demand for its blockbuster weight loss and diabetes injections soars and the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Investments, Pharma, Pharma / Biotech, Trends
Eikon raises $351M in one of the year’s largest biotech venture rounds
How AI Drug Manufacturing Is Changing the Game
Radiopharmaceutical Manufacturing: A High-Stakes Race Against Time
Will Pharma Continue Efforts to Diversify Clinical Trials?
InnovationRx: Eli Lilly Has Stockpiled Nearly $550 Million Of Its Next Obesity Drug

Share This Article